Alnylam Pharmaceuticals News

Alnylam Pharmaceuticals | 8-K: Alnylam Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Period Activity

May 2 08:13 ET

Alnylam Pharmaceuticals | DEFA14A: Others

Apr 1 16:42 ET

Alnylam Pharmaceuticals | DEF 14A: Definitive information statements

Apr 1 16:34 ET

Alnylam Pharmaceuticals | 8-K: Current report

Mar 4 16:37 ET

Alnylam Pharmaceuticals | 8-K: Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Period Activity

Feb 15 08:12 ET

Alnylam Pharmaceuticals | 8-K: Current report

Jan 19 00:00 ET

Alnylam Pharmaceuticals | 8-K: Current report

Jan 8 00:00 ET

Alnylam Pharmaceuticals | 8-K: Alnylam Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Period Activity

Nov 2, 2023 08:10 ET

Alnylam Pharmaceuticals | 8-K: Current report

Oct 10, 2023 07:30 ET

Alnylam Pharmaceuticals | 8-K: Current report

Sep 28, 2023 17:00 ET

Alnylam Pharmaceuticals | 8-K: Alnylam Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Period Activity

Aug 3, 2023 08:10 ET

Alnylam Pharmaceuticals | 8-K: Current report

Jul 26, 2023 17:15 ET

Alnylam Pharmaceuticals | 8-K: Current report

Jun 30, 2023 09:03 ET

Alnylam Pharmaceuticals | 8-K: Current report

May 23, 2023 16:30 ET

Alnylam Pharmaceuticals | 8-K: Alnylam Pharmaceuticals Reports First Quarter 2023 Financial Results and Highlights Recent Period Activity

May 4, 2023 08:10 ET

Alnylam Pharmaceuticals | DEFA14A: Others

Apr 3, 2023 16:34 ET

Alnylam Pharmaceuticals | DEF 14A: Definitive proxy statements

Apr 3, 2023 16:32 ET

Alnylam Pharmaceuticals | 8-K: Current report

Mar 8, 2023 16:30 ET

Alnylam Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 23, 2023 16:03 ET

Alnylam Pharmaceuticals | 8-K: Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Period Activity

Feb 23, 2023 08:10 ET